03.07.2018 • News

Kamal Abbasi Joins Kamedis’ Board of Director

Kamedis, a provider of products for the treatment of chronic skin disorders, announced the addition of Kamal Abbasi to its board of directors. Abbasi formerly served as area vice president of Nestle Skin Health’s Galderma business for Asia Pacific. He is currently vice president at Sinclair Pharma with responsibility for Asia Pacific, Middle East/North Africa and Central/Eastern Europe.

Abbasi, a British citizen, is a medical doctor and obtained his degree from the Sindh Medical University in Karachi, Pakistan. His appointment coincides with a major growth initiative by Kamedis in Central and Eastern Europe.

Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read